87 related articles for article (PubMed ID: 19748126)
21. Bifunctional 3-hydroxy-4-pyridinones as effective aluminium chelators: synthesis, solution equilibrium studies and in vivo evaluation.
Irto A; Cardiano P; Chand K; Cigala RM; Crea F; De Stefano C; Gano L; Sammartano S; Santos MA
J Inorg Biochem; 2018 Sep; 186():116-129. PubMed ID: 29885988
[TBL] [Abstract][Full Text] [Related]
22. Aluminum chelation by 3-hydroxypyridin-4-ones in the rat demonstrated by microdialysis.
Yokel RA
Biol Trace Elem Res; 1996; 53(1-3):193-203. PubMed ID: 8862748
[TBL] [Abstract][Full Text] [Related]
23. Thorium(IV) complexes of bidentate hydroxypyridinonates.
Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
[TBL] [Abstract][Full Text] [Related]
24. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
[TBL] [Abstract][Full Text] [Related]
25. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions.
Kullgren B; Jarvis EE; An DD; Abergel RJ
Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of New Bis(3-hydroxy-4-pyridinone) Ligands as Chelating Agents for Uranyl Complexation.
Jin B; Zheng R; Peng R; Chu S
Molecules; 2016 Mar; 21(3):299. PubMed ID: 27005598
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy.
Allen DD; Orvig C; Yokel RA
Toxicology; 1994 Sep; 92(1-3):193-202. PubMed ID: 7940560
[TBL] [Abstract][Full Text] [Related]
29. A new bis(3-hydroxy-4-pyridinone)-IDA derivative as a potential therapeutic chelating agent. Synthesis, metal-complexation and biological assays.
Amélia Santos M; Gama S; Gano L; Cantinho G; Farkas E
Dalton Trans; 2004 Nov; (21):3772-81. PubMed ID: 15510305
[TBL] [Abstract][Full Text] [Related]
30. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
31. Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.
Kruck TP; Cui JG; Percy ME; Lukiw WJ
Cell Mol Neurobiol; 2004 Jun; 24(3):443-59. PubMed ID: 15206824
[TBL] [Abstract][Full Text] [Related]
32. Acute aluminium intoxication: a study of the efficacy of several antidotal treatments in mice.
Domingo JL; Llobet JM; Gómez M; Corbella J
Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):93-104. PubMed ID: 3749610
[TBL] [Abstract][Full Text] [Related]
33. DFT investigation on the selective complexation of Fe
Kaviani S; Izadyar M; Housaindokht MR
J Mol Graph Model; 2018 Mar; 80():182-189. PubMed ID: 29414037
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamic remarks on chelating ligands for aluminium related diseases.
Crisponi G; Nurchi VM
J Inorg Biochem; 2011 Nov; 105(11):1518-22. PubMed ID: 22099162
[TBL] [Abstract][Full Text] [Related]
36. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
Devanur LD; Evans RW; Evans PJ; Hider RC
Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
[TBL] [Abstract][Full Text] [Related]
37. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation.
Nurchi VM; Cappai R; Chand K; Chaves S; Gano L; Crisponi G; Peana M; Zoroddu MA; Santos MA
Dalton Trans; 2019 Nov; 48(43):16167-16183. PubMed ID: 31577287
[TBL] [Abstract][Full Text] [Related]
38. A novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in vivo studies.
Chaves S; Capelo A; Areias L; Marques SM; Gano L; Esteves MA; Santos MA
Dalton Trans; 2013 May; 42(17):6033-45. PubMed ID: 23223558
[TBL] [Abstract][Full Text] [Related]
39. A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species.
Chaves S; Mendonça AC; Marques SM; Prata MI; Santos AC; Martins AF; Geraldes CF; Santos MA
J Inorg Biochem; 2011 Jan; 105(1):31-8. PubMed ID: 21134600
[TBL] [Abstract][Full Text] [Related]
40. N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles.
Santos MA; Gil M; Marques S; Gano L; Chaves S
Anal Bioanal Chem; 2005 Jan; 381(2):413-9. PubMed ID: 15455189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
